Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective study
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgaf038 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Tomoyuki Ishigo und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Sapporo Medical University Hospital, Sapporo, Japan. Hauptthemen laut MEDLINE: Vancomycin, Creatinine, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
In patients with diminished muscle mass, serum creatinine (SCr) levels may be misleadingly low, potentially leading to overestimations of kidney function and unexpectedly high blood levels of vancomycin. This study aimed to identify factors contributing to this discrepancy and develop a flowchart for stratifying the risk of excessive vancomycin exposure, measured as an upward deviation in the area under the concentration–time curve (AUC) in patients with low SCr levels.
Methods
We analyzed data from patients who received vancomycin and had an SCr value <0.6 mg/dL. The discrepancy between the AUC24–48 h initial dosing and AUC24–48 h TDM was calculated; a ratio (AUC24–48 h TDM/AUC24–48 h initial dosing) higher than 1.2 defined an upward deviation in the AUC. A decision tree model was constructed using classification and regression tree algorithms.
Results
Among the 95 patients (median age [interquartile range], 69 [58, 80] years; 68% female), the upward AUC deviation was 40% (38/95). Three factors (creatinine clearance: 115 ml/min, age: 69 years, and blood urea nitrogen/SCr: 17) were selected for the decision flowchart and included in four subgroups.
Conclusion
We developed a flowchart to identify patients with low SCr levels whose AUC at therapeutic drug monitoring deviated upward by >20% from the predicted AUC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Sapporo Medical University Hospital, Sapporo, Japan.
- Laboratory of Clinical Pharmacokinetics, School of Pharmacy, Kitasato University, Sagamihara, Japan.
- Department of Pharmacy, Kitasato University Hospital, Sagamihara, Japan.
- Department of Pharmacy, Showa Medical University Hospital, Tokyo, Japan.
- Department of Pharmacy, Kyorin University Hospital, Mitaka, Japan.
- Department of Hospital Pharmaceutics, School of Pharmacy, Showa Medical University, Tokyo, Japan.
ORCID-Profile: Tomoyuki Ishigo, Masaru Samura, Yuki Enoki, Kazuaki Taguchi, Kazuaki Matsumoto
Zitieren
APA
Ishigo, T., Suzuki, A., Ibe, Y., Fujii, S., Fukudo, M., Yoshida, H., Tanaka, H., Fujihara, H., Yamaguchi, F., Ebihara, F., Maruyama, T., Hamada, Y., Samura, M., Nagumo, F., Komatsu, T., Tomizawa, A., Takuma, A., Chiba, H., Nishi, Y., …, & Matsumoto, K. (2025). Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective study. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf038
Vancouver
Ishigo T, Suzuki A, Ibe Y, Fujii S, Fukudo M, Yoshida H, et al. Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective study. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf038
BibTeX
@article{Ishigo2025,
author = {Ishigo, Tomoyuki and Suzuki, Ayako and Ibe, Yuta and Fujii, Satoshi and Fukudo, Masahide and Yoshida, Hiroaki and Tanaka, Hiroaki and Fujihara, Hisato and Yamaguchi, Fumihiro and Ebihara, Fumiya and Maruyama, Takumi and Hamada, Yukihiro and Samura, Masaru and Nagumo, Fumio and Komatsu, Toshiaki and Tomizawa, Atsushi and Takuma, Akitoshi and Chiba, Hiroaki and Nishi, Yoshifumi and Enoki, Yuki and Taguchi, Kazuaki and Matsumoto, Kazuaki},
title = {Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective study},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgaf038}
}
EUVIMED